Is EWTX undervalued or overvalued?

As of 2025-03-21, the Intrinsic Value of Edgewise Therapeutics Inc (EWTX) is -7.03 USD. This EWTX valuation is based on the model Peter Lynch Fair Value. With the current market price of 23.82 USD, the upside of Edgewise Therapeutics Inc is -129.50%. This means that EWTX is overvalued by 129.50%.

Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.

	Range	Selected	Upside
a
Fair Value	-7.03 - -7.03	-7.03	-129.50%
P/E	(26.00) - (26.56)	(27.48)	-215.4%
DDM - Stable	(16.92) - (100.97)	(58.95)	-347.5%
DDM - Multi	(0.77) - (3.59)	(1.27)	-105.3%